Tumor-infiltrating regulatory T cells (Treg) express a high amount of the PD-1 receptor so that it can interact with PD-L1 and PD-L2, resulting in the inhibition of the antitumor immune response [77]. The gene discussed is PDCD1LG2; the disease is neoplasm.